GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Bax | multiple interactions | EXP | | 6480464 | CTD | Niacinamide inhibits the reaction [Methylnitrosourea results in increased expression of BAX protein]; Niacinamide inhibits the reaction [Thiotepa results in increased expression of BAX mRNA]; Niacinamide inhibits the reaction [Thiotepa results in increased expression of BAX protein] | PMID:16168987 PMID:22164206 | Bax | increases expression | ISO | BAX (Homo sapiens) | 6480464 | CTD | Niacinamide results in increased expression of BAX mRNA; Niacinamide results in increased expression of BAX protein | PMID:16998810 PMID:26712469 | Bax | multiple interactions | ISO | Bax (Mus musculus) | 6480464 | CTD | [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX mRNA]; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX protein]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX mRNA]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX protein] | PMID:25478867 | Bax | multiple interactions | ISO | BAX (Homo sapiens) | 6480464 | CTD | [Berberine co-treated with Niacinamide] results in increased expression of BAX protein | PMID:26712469 | | ||||||||||||||||||||||
| Go Back to source page | Continue to Ontology report |